Dominant T cell receptor clonotypes in adrenocorticotropic hormone-secreting pituitary carcinoma are the highest-frequency clones among CD4+ and CD8+ cells in peripheral blood during effective anti-PD-1 therapy
Mariko Sugiyama, Shintaro Iwama, Kazuhito Takeuchi, Tomoko Kobayashi, Takanori Murase, Daisuke Hagiwara, Hao Chen, Yuichi Nagata, Ryuta Saito, Yoshiki Akatsuka, Hiroshi Arima · 2026
Read Dominant T cell receptor clonotypes in adrenocorticotropic hormone-secreting pituitary carcinoma are the highest-frequency clones among CD4+ and CD8+ cells in peripheral blood during effective anti-PD-1 therapy by Mariko Sugiyama, Shintaro Iwama, Kazuhito Takeuchi, Tomoko Kobayashi, Takanori Murase, Daisuke Hagiwara, Hao Chen, Yuichi Nagata, Ryuta Saito, Yoshiki Akatsuka, Hiroshi Arima (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311078.txt.
Description
Mariko Sugiyama and colleagues track immune cell clones in a rare pituitary cancer during checkpoint therapy in a 2026 case study. A woman aged 34 years with Lynch syndrome had a hormone secreting pituitary carcinoma that spread to the liver. A PD-1 blocking drug held disease steady for over a year, and predictors of response were unknown.
Untreated tumor tissue held both helper and killer T cells. Gene codes for T cell receptors showed top tumor clones also ruled the blood during good response, topping both cell groups. A later ovary spread held fewer helper cells in tissue. Blood tracking of tumor clones may mirror response.
Catalog record
| CREATOR | Mariko Sugiyama, Shintaro Iwama, Kazuhito Takeuchi, Tomoko Kobayashi, Takanori Murase, Daisuke Hagiwara, Hao Chen, Yuichi Nagata, Ryuta Saito, Yoshiki Akatsuka, Hiroshi Arima |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19925 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |